Flavonoid Market Report: Trends, Forecast and Competitive Analysis to 2035

Flavonoid Market

The future of the global flavonoid market looks promising with opportunities in the food & beverage, nutraceutical, pharmaceutical, cosmetic & personal care, and animal feed markets. The global flavonoid market is expected to reach an estimated $3.1 billion by 2035 from $2.2 billion in 2027 with a CAGR of 5.1% from 2027 to 2035. The major drivers for this market are the increasing demand for natural antioxidant rich products, the rising use in functional food beverages and supplements, and the growing preference for plant based health ingredients.

• Lucintel forecasts that, within the type category, anthocyanin will remain the largest segment over the forecast period due to rising demand for natural colorants and antioxidant properties.
• Within the application category, nutraceutical will remain the largest segment over the forecast period due to growing health supplement consumption trends.
• In terms of regions, North America will remain the largest region over the forecast period due to strong market presence and increasing consumer awareness levels.

Emerging Trends in Flavonoid Market

The market is shifting toward standardized ingredients within a nutraceutical, functional food, cosmetic, and pharmaceutical context. By 2027,the market will reflect an increased focus on clinical studies, as well as the processing of cleaner, safer products, more compliance, and sourcing that is more regional. Lucintel's projections show that for the foreseeable future demand will gravitate toward suppliers that provide potent and safe ingredients that are consistent and assured.

• Clinical Validation: An increase in human studies, and subsequent clinical validation, is more evident within quercetin, anthocyanins, and citrus flavonoids. For the next five years, the purchasing trend will move toward buying studies that support the claims made on the label, as evidence will become more important.
• Standardization: Manufacturing is more inclined to use extracts that are defined by marker compounds in place of variable plant powders. Identity and dosage concerns in the European supplement enforcement of 2025 will create more demand for standardized specifications. This, in turn, will create more opportunities for pricing that is less risky.
• Clean-label Processing: 2025 will see an increased emphasis on water-based extractions, solvent recoveries, and processing at lower temperatures. This will address the concerns of consumers over residues and the impact of processing on the environment.
• Functional Product Integration: Food and beverage companies are utilizing flavonoids in the development of products marketed in the areas of immunity, healthy aging, and cognitive health, as well as in other health-related areas. Insights from 2025 indicate an expansion of this trend. This will create a demand for innovative formats that ensure greater convenience for the consumer and a higher likelihood of repeat purchasing.
• Supply-chain Regionalization: Volatility in the climate and export controls have companies thinking about using more than one source for citrus, berries, tea, and other botanicals. Dual sourcing became especially important in 2025 when freight disruptions again exposed heavy reliance on very few international trade routes. Regional processing capacity will become very important as buyers are looking for shorter lead times, and more importantly, more consistent and traceable origin.

The market is changing. Evidence, consistency, and practical formulation support now become core offerings to replacing raw volume growth as the main market driver. Suppliers who specialize in botanical sourcing should gain more market share. Large ingredient companies are well positioned to serve regulator needs, develop clinical studies, and offer more flexible sourcing and supply contracts.

Recent Developments in the Flavonoid Market

The Market for Flavonoids is Booming as Manufacturers of Dietary Supplements and Functional Foods Use Technology Developed for Botanical Drug Research. From 2025 to 2027, Both Suppliers and Brands will Look for Standardized Extracts and Cleaner Technologies. There Are Many Capacity Expansions and Changes to Regulations Planned for This Year and Next. Lucintel Believes These will be the More Important Impacts to the Market.

• Increases in Capacity Funding: In February 2025, A European Ingredient Producer Earmarked €12 Million to Fund New Capacity for Polyphenol Extraction, Including Flavonoids From Citrus. Increased Capacity Will Allow Greater Supply Stability and Enable Large Corporate Buyers of Supplements and Nutraceuticals to Enter Long-Term Contracts with Suppliers.
• Highly Bioavailable Clinical Grade Ingredients: In April 2025 a Supplier of Specialty Ingredients Produced a Quercetin Ingredient at a 95% Level of Purity and Backed This Ingredient with a Bioavailability Study. This Has Shifted the Competition from Pricing for Extracts to Competition for Proven Absorption and Formulation Effectiveness.
• Collaborative Efforts: In June 2025, A Botanical Ingredient Producer Announced a Joint Effort with a University Research Group to Study Four Domains of Metabolic Health in Relation to Flavonoids. These Efforts Provide Suppliers of Ingredients with Strong Evidence to Support Their Premium Pricing and Desired Regulatory Positions.
• Cleaner Technologies. In September 2025, Another Extraction Company Introduced a Line Of Technology to Produce at a 500 Tonne Annual Capacity Using Water. This New Technology Will Allow Cleaner Processing and Address Concerns of Food, Beverages, and Supplements Manufacturers as they Implement Sustainability Goals and Audit their Suppliers.
• Expanding Regulations in Supplements: In November 2025, A Regulatory Agency in Asia Approved the Use of Three Formulations that Contained Flavonoids for Use in Functional Foods. While More Regulations will Increase Demand in This Region, Manufacturers Still Need to Meet Tighter Specifications, Reduced Contaminant Levels, and Have Permitted Language for Health Claims.

These trends advance the flavonoid market from the extraction stage to the formulation-ready stage. Investors care more about traceability, clean technology, and the clinical validation of extracts, rather than extract volumes. Within the next five years, formulation contracts will be awarded to suppliers who can guarantee consistency in botanical inputs and document bioavailability. Smaller extractors who lack analytical capacity will face shrinking margins and consolidation of the supply chains.

Strategic Growth Opportunities in the Flavonoid Market

The period between 2024 and 2026 will see a shift in demand more towards evidence-based ingredients. Lucintel's market view shows potential in the food coloring and preservation market due to more regulations in the supplement industry, greater natural color options, and higher value opportunities for agricultural by-products.

• Clinical nutrition applications will see quercetin, hesperidin and anthocyanin formulations be used in cardiometabolic and immune health products. In March 2025, a clinical-trial registry showed over 30 quercetin intervention studies. In the next three to five years, formulations will see more demand based on the evidence that leads to a higher price and more recommendations from pharmacists.
• Functional beverages will utilize flavonoid concentrates in reduced sugar formulations that do not rely on artificial sweeteners in drinks, shots, and powdered beverage hydration formats. In January 2025, Innova Market Insights reported health claims on 28% of global beverage launches. Portable formats will increase access for consumers and volume of ingredients through 2030.
• Pharmaceutical excipients and therapeutics will see inflammation, vascular health, and oncology support research use purified flavonoids. In June 2025, ClinicalTrials.gov showed over 1,000 studies. Evidence will move flavonoids from supplements and personal care to therapeutic use.
• Personal care actives will benefit from flavonoids from citrus, tea, and grape in supporting antioxidant, brightening, and sensitive skin formulations. In April 2025, L'Oreal reported 22% growth in dermatological beauty sales for the previous year. Formulations will become more expensive when brands invest in extracts that have been standardized and shown to have positive benefits for the skin.
• Upcycled Raw Materials: Processors have the opportunity to create economic flavonoid feedstocks from peels, seeds, and pomace streams. The European Commission projected EU food waste at 58 million tons in February 2025. Converting waste to marketable actives increases profits and helps manufacturers satisfy zero-waste objectives and procurement goals.

Suppliers of flavonoids should focus less on extraction volume competition and more on validated efficacy, consistent sourcing, and formulation. The best positions will integrate the convenience of regulated delivery formats. Partnerships with manufacturers of food, pharmaceuticals, and personal care items can shorten the time to a marketable product. Ultimately, a supplier's ability to expand their margin will depend on the ability to provide a consistent sourcing from farm to market with consistent potency of flavonoids through varying agronomic conditions and trade dynamic changes."

Flavonoid Market Drivers and Challenges

Technological, economic, regulatory and environmental factors play a key role in shaping the flavonoid market. Growing interest in preventive care, as well as functional foods, supplements and ingredients of natural origin, is increasing market demand. Improving extraction and formulation technologies enhance product quality and expand market potential with greater versatility of applications. Sustainability has an influence on sourcing and processing. Regulatory standards impact claims, safety, and market access. According to Lucintel, growth in the flavonoid market in the coming years will be determined by innovation, consumer preferences and supply-chain dynamics.

The major growth drivers for the flavonoid market are:

• Customer Demand: Rising interest among consumers in immunity and healthy aging, cardiovascular health and plant-based nutrition is creating demand for flavonoid-enriched foods, beverages, dietary supplements, and cosmetics. In January 2025, the World Health Organization once more emphasized the importance of a diet rich in fruits and vegetables, a widely recognized dietary source for flavonoids. This increasing demand enables manufacturers to produce food and dietary supplements that are cleaner and contain recognizable botanical ingredients. During the next three to five years, the market for standardized extracts, functional beverages and dietary supplements in an easy to use format is expected to grow as a result of personalized nutrition, greater awareness of preventive health care and the growing middle class.
• Technology Advancements: New technologies for extraction, purification, and microencapsulation have improved stability and consistency of flavonoids for use in various products over the past few years. It was published in March 2025 that some polyphenols and particularly flavonoids, can be improved by encapsulation for controlled release with increased stability. Flavonoids can now be used in drinks, milk substitutes, and personal care products as well as medication. Innovations in the processing and formulations of the next few years will help overcome limitations in formulations and increase the certainty of dosages. Further improvement in analytical methods will help manufacturers ensure high quality of products and distinguish superior formulations.
• Regulatory Support: Development of more consistent regulations in regards to health claims for foods and develop health claim frameworks and increased consistency in botanical compound regulatory frameworks will drive private investment in flavonoid production. In April 2025, the European Union continued to require claims on foods and supplements to be substantiated. While this can be difficult, predictable regulations increase consumer trust and certainty for law-abiding producers. During the next 3 to 5 years, the development of harmonized standards will emphasize and promote more efficacious companies that are able to better control their products, demonstrate integrity of their practices, and remain transparent. Thus, improved regulations will favor safe and reliable international business.
• Sustainability: Increasing customer preference for naturally sourced and sustainably sourced ingredients has spurred the use of agricultural by-product, low-solvent extraction, renewable energy, and traceable botanical supply chains. In 2025, the European Commission continued the implementation of its circular economy initiatives and stimulated interest in waste reduction and resource efficiency. During this time, value-adding citrus peel, grape skin, and processing residue extraction can reduce burden. It is predicted that the sustainable credential of a product will become a differentiator in procurement, acceptance by retailers, and brand position in the market over the next three to five years, though suppliers need to defend the sustainability of their products through credible lifecycle assessment.
• Product Innovation: There has been a shift in use of flavonoids beyond their traditional uses in capsules to incorporation in fortified beverages, gummies, sports nutrition, skincare products, and pharmaceuticals. In conjunction with this, in 2025, the global market continued to grow in plant-based antioxidant functional-food product launches, illustrating a continued growth in customer acceptance of products in convenient wellness formats. Additionally, the focus of innovation is likely to be on flavonoid co-formulation with vitamins, minerals, and probiotics, as well as other bioactive compounds. It is likely that over the next three to five years, the market value will be shifted in favor of products that utilize innovative delivery systems and taste-masking technologies, as well as products that utilize clinically supported formulations.

This Market is faced with the following challenges:

• Supply Chain Volatility: Seasonal crops and unpredictable geographic distributions lead to fluctuations in the availability of flavonoids as do weather, transportation, and the costs of agricultural inputs. In its January 2025 report, the Food and Agriculture Organization continued to monitor climate variability and its adverse impact on the agricultural production of multiple regions, which also has an obvious impact on botanical raw materials. There are challenges of variable quality in the consistency of harvests and fluctuations in prices and the ability to forge long-term agreements. During the next 3-5 years, disruptions from climate change will increase procurement costs and encourage manufacturers to source raw materials from more suppliers, implement controlled cultivation, utilize agricultural waste, and adopt policies of larger raw material inventories. There will be a heightened concern for factor risks and the origin and quality of raw materials.
• Bioavailability and Evidence Gaps: Despite the promising pre-clinical and early clinical results of certain flavonoids, there are large and often surprising gaps that remain as to their absorption, metabolism, dose, and overall impact on human health. In May 2022, scientific reviews continued to identify bioavailability as one of the key constraints for the translation of polyphenol research into marketable health outcomes. Poor flexible absorption also impacts consumer satisfaction and products may become subject to ongoing regulation. The next 3-5 years may require a company to fund clinical studies on delivery systems and metabolic studies, as well as standardized testing. Companies unwilling to invest in consistent product efficacy may lose trust, leading to lowered prices and difficulty securing professional recommendations.
• Regulatory and Quality Complexity: Flavonoid products have varying regulations across the food, supplement, cosmetic and pharmaceutical industries, making distinct requirements for claims, purity, contaminants, labels, and documentation. In September 2025, regulators in key markets intensified their focus on health claims and the quality of ingredients. This poses a challenge for botanical products. Diverging regulations increase costs and prolong time to market, particularly for smaller companies going global. In the next 3 to 5 years, companies with validated methods, clinical studies, and efficient traceability within good manufacturing practices will benefit from the focus on compliance. Poorly documented products will either be removed or repositioned.

The flavonoid market continues to show potential for long term growth as consumer demand drives the use of more natural remedies for health, wellness, and anti-aging practices. Advancing technology and innovation increases commercial viability of flavonoid ingredients spanning food, supplements, cosmetics, and pharmaceuticals. However, challenges such as Lack of consistency in supply and bioavailability evidence, as well as compliance in different regions, will continue to create friction for market leaders. These companies will have to improve their sourcing, justify their science, and improve the sustainability of their operations while simultaneously offering innovative products. Overall, market leaders will likely benefit from improving the quality of their products, delivering health benefits, and adapting to rapid changes in customer and regulatory concerns.

List of Flavonoid Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies flavonoid market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the flavonoid market companies profiled in this report include-

• Indena S.p.A
• Layn Natural Ingredients
• The Merck Group
• Cayman Chemical Company
• Extrasynthese
• Foodchem International Corporation
• DSM-Firmenich AG
• The Archer-Daniels-Midland Company
• Cargill, Incorporated
• Givaudan S.A.

Flavonoid Market by Segment

The study includes a forecast for the global flavonoid market by type, source, form, application, and region.

Flavonoid Market by Type [Value ($B) from 2019 to 2035]:

• Anthocyanin
• Flavones
• Flavan-3-ols
• Flavonol
• Anthoxanthin
• Isoflavones
• Others

Flavonoid Market by Source [Value ($B) from 2019 to 2035]:

• Citrus Fruits
• Berries
• Soybeans
• Tea
• Cocoa
• Herbs & Spices
• Others

Flavonoid Market by Form [Value ($B) from 2019 to 2035]:

• Powder
• Liquid
• Others

Flavonoid Market by Application [Value ($B) from 2019 to 2035]:

• Food & Beverages
• Nutraceutical
• Pharmaceutical
• Cosmetic & Personal Care
• Animal Feed

Flavonoid Market by Region [Value ($B) from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Flavonoid Market

The food, supplements, and pharmaceutical industries are moving from using bulk botanical extracts to using standardized and clinically substantiated ingredients. From 2025 to 2027, regulatory oversight, domestic manufacturing policies, and investments in extraction and formulation will affect supply chains. In its most recent market study, Lucintel has found that these developments will provide further support for regional production approaches.

• United States: Regulatory qualification and commercialization: In January of 2025, the FDA updated its NDI notification inventory to include numerous plant-based polyphenol ingredients. This was followed by the major supplement companies making clinically substantiated flavonoid formulations. This is important because there will be greater compliance pathways and evidence requirements. Standardized composition and safety dossiers will become requirements. There will be greater market pressure on differentiated extract suppliers.
• China: Capacity and export-oriented processing: The policies for 2025 pharmaceutical and health-food manufacturing introduced by the Chinese government continued to support high-value botanical ingredients along with new investments in automated extraction and spray-drying equipment. Extensive new investments in extraction capacity have been reported and typically increase capacities in the thousands of metric ton range (March 2025). This will strengthen China's market position in low-cost extraction of flavonoids and increase market pressure on exporters to meet higher quality standards.
• Germany: Industrial partnerships and sustainable processing: German ingredient companies continued to link botanical extraction with clean-label and circular-processing. BASF reported over 112,000 employees worldwide and continued to make investments in biotechnology and nutrition-related solutions in April 2025. German manufacturers are requiring from flavonoid suppliers certified sourcing, solvent control, and lifecycle data.
• India: Manufacturing & exports: In 2025, India continued to administer its production-linked incentive and its pharmaceutical sector programs. Meanwhile, botanical ingredient companies created offerings of standardized curcumin, quercetin, and citrus bioflavonoids. Within the Department of Pharmaceuticals' 2025 budget of ₹4,000 crore (February), local level extraction, testing and formulation capacity was invested, positively influencing India's status in regulated nutraceutical as well as pharmaceutical value chains.
• Japan: Product launches & integrated functional food: Japanese food and ingredients companies continued to market products based on food combinations of flavonoid-rich citrus, tea, and berries and Japanese Consumer Affairs Agency had more than 7,000 Foods with Function Claims by March 2025. This trend will particularly influence demand by incorporating standardized flavonoids in convenience-type foods and beverages rather than relying on standalone supplements.

Features of the Global Flavonoid Market

• Market Size Estimates: flavonoid market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
• Segmentation Analysis: flavonoid market size by various segments, such as by type, source, form, application, and region in terms of value ($B).
• Regional Analysis: flavonoid market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, sources, forms, applications, and regions for the flavonoid market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the flavonoid market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the flavonoid market by type (anthocyanin, flavones, flavan-3-ols, flavonol, anthoxanthin, isoflavones, and others), source (citrus fruits, berries, soybeans, tea, cocoa, herbs & spices, and others), form (powder, liquid, and others), application (food & beverages, nutraceutical, pharmaceutical, cosmetic & personal care, and animal feed), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?